KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Operating Leases (2021 - 2024)

Historic Operating Leases for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $242.0 million.

  • BioNTech SE's Operating Leases changed N/A to $242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.0 million, marking a year-over-year change of. This contributed to the annual value of $271.6 million for FY2024, which is 1650.43% up from last year.
  • As of Q3 2025, BioNTech SE's Operating Leases stood at $242.0 million.
  • BioNTech SE's Operating Leases' 5-year high stood at $14.3 billion during Q1 2022, with a 5-year trough of $207.7 million in Q4 2021.
  • For the 5-year period, BioNTech SE's Operating Leases averaged around $4.4 billion, with its median value being $271.6 million (2024).
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 39501.71% in 2022, then tumbled by 9676.68% in 2024.
  • BioNTech SE's Operating Leases (Quarter) stood at $207.7 million in 2021, then increased by 3.18% to $214.4 million in 2022, then grew by 8.77% to $233.2 million in 2023, then grew by 16.5% to $271.6 million in 2024, then decreased by 10.91% to $242.0 million in 2025.
  • Its Operating Leases was $242.0 million in Q3 2025, compared to $260.5 million in Q2 2025 and $259.6 million in Q1 2025.